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Abstract 
Background: 
Remote monitoring of symptoms in Parkinson’s Disease (PD) using body-worn sensors would assist 
treatment decisions and evaluation of new treatments. To date, a rigorous, systematic evaluation of 
the acceptability of body-worn sensors in PD has not been undertaken.   
Materials and Methods:  
34 participants wore bilateral wrist-worn sensors for four hours in a research facility and then for 
one week at home. Participants’ views on the sensors were captured using a Likert-style 
questionnaire after each phase. Qualitative data were collected through free-text responses. 
Differences in responses between phases were assessed for using the Wilcoxon rank-sum test. 
Content analysis of qualitative data was undertaken. ‘Non-wear time’ was estimated via analysis of 
accelerometer data for periods when sensors were stationary. 
Results: 
After prolonged wearing there was a negative shift in participants’ views on the comfort of the 
sensor; problems with the sensor’s strap were highlighted. However, accelerometer data 
demonstrated high patient concordance with wearing of the sensors. There was no evidence that 
participants were less likely to wear the sensors in public. Most participants preferred wearing the 
sensors to completing symptom diaries.  
Discussion: 
The finding that participants were not less likely to wear the sensors in public provides reassurance 
regarding the ecological validity of the data captured. The validity of our findings was strengthened 
by triangulation of data sources, enabling patients to express their agenda and repeated assessment 
after prolonged wearing. 
Conclusions: 
Long-term monitoring with wrist-worn sensors is acceptable to this cohort of PD patients. Evaluation 
of the wearer’s experience is critical to the development of remote-monitoring technology.  
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1 Introduction   
The motor symptoms of Parkinson’s disease (PD) include tremor, rigidity and bradykinesia. With 
prolonged levodopa therapy motor complications such as dyskinesia (additional, involuntary 
movements) may develop(1). The fluctuations seen in PD render quantification of symptoms 
challenging. Current gold-standard assessment methods include clinical rating scales(2) and patient-
completed symptom diaries, both of which are inherently subjective(3-5).  
Body-worn accelerometers have shown great promise as an objective measure of PD symptoms. 
Accurate detection of tremor(6), bradykinesia(7) and dyskinesia(8) has previously been 
demonstrated and accelerometers have been employed for prolonged periods of remote symptom 
monitoring(9). Remote monitoring technology (RMT) of patients’ symptoms may enable more 
informed treatment decisions to be made and the field has been identified as a key research area for 
the PD community(10). These methods may also yield data for use as an outcome measure for 
evaluation of new treatments(11). It is recognised that adoption of RMT is dependent on 
perceptions of the user(12), yet a recent review article highlighting the growing interest of such 
technology in PD made no reference to any work evaluating the acceptability of such sensors to the 
wearers(13).  
No previous work has formally evaluated whether participants are truly concordant with the wearing 
of such sensors. Establishing the acceptability of long-term use of body-worn sensors in the home is 
therefore essential if RMT is to be successfully implemented. We therefore aimed to evaluate the 
acceptability of wrist-worn sensors in a PD population following assessment after both brief, and 
prolonged, periods of wearing. 
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2 Materials and Methods 
Ethical approval:  
A favourable ethical opinion was provided by County Durham and Tees valley Research Ethics 
Committee. 
Subjects and recruitment:  
34 subjects were recruited; all of whom provided informed written consent. This study forms part of 
research exploring the use of accelerometers to assess upper limb motor symptoms in PD, the 
analysis of which is on-going. Patients from the Northumbria PD service who fulfilled the following 
inclusion criteria were recruited: aged >18years, diagnosis of idiopathic PD (United Kingdom Brain 
Bank Criteria(14)), Hoehn and Yahr(15) stages I-IV, not significantly cognitively impaired (Mini-
Mental State Examination(16) of >24) and taking immediate-release levodopa medication. All 
participants provided informed consent for involvement.  
Body-worn sensor:  
The sensor (Axivity AX-3)(17) is a waterproof tri-axial accelerometer, which was attached by an 
adjustable Velcro strap (overall weight 35g). It allows continuous sensing for up to 12 days without 
the need for recharging. Participants wore a sensor on each wrist (Figure 1) in two different study 
phases. 
Phase 1: Participants attended Newcastle University’s Clinical Ageing Research Unit (CARU) and wore 
the sensors continuously for approximately four hours whilst undergoing clinical assessments.  
Phase 2: Participants wore the sensors continuously at home with no clinician input for one week, 
whilst also completing symptom diaries. Participants were briefed to wear the sensors continuously 
and to go about their daily activities as normal, but were advised to discontinue wearing them 
should they become burdensome. Despite the sensors being waterproof, participants were invited 
to remove the sensors during washing/bathing if they preferred to do so. 
Outcome measures:  
A questionnaire was developed to capture participants’ opinions regarding the sensors. The 
questionnaire was piloted on a volunteer participant to ensure clarity and readability, and adapted 
in response to feedback. The questionnaire included nine items (Table 1) and for each item 
participants indicated their level of agreement on a symmetrical five-point Likert scale. The 
questionnaire also included a space for participants to provide free-text feedback about the sensors. 
The same questionnaire was administered on completion of both study phases and was returned to 
researchers in a pre-paid envelope. 
The amount of time that the sensors were not worn during the home monitoring period was 
estimated by analysis of accelerometer data. Data were examined for minute-long periods for which 
no orientation change of the sensor was seen. If 10 or more such minutes occurred consecutively, 
then the full period was classified as time when the sensor was not being worn. To avoid inadvertent 
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classification of sleep as periods where sensors were not worn, analysis of accelerometer data was 
restricted to waking hours (defined as 0800 – 2200). 
Data analysis:  
IBM-SPSS software was used to collate responses and to produce descriptive statistics. Likert 
response categories were treated as ordinal data, since the intervals between categories cannot be 
assumed to be of equal magnitude. Significant differences between participants’ phase one and two 
responses were assessed by using the Wilcoxon rank-sum test. Content analysis of free text 
responses was undertaken. All free-text responses provided were transcribed verbatim. A coding 
framework was developed to describe the content of the responses (by JF). Comments were 
categorised by over-arching theme, sentiment (positive or negative) and by study phase (CARU or 
home). An experienced qualitative researcher (KG), who had no prior involvement with this project, 
also performed content analysis. The second researcher received transcripts of the free-text 
comments but was blinded to the content analysis performed by the first researcher. Thereafter, 
both researchers met to compare analyses and to explore alternate interpretations/coding 
strategies, a process recognised as improving rigour in content analysis(18). Consensus opinion was 
reached on the most appropriate content analysis themes from the data captured.  
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3 Results 
Questionnaire: Quantitative data 
A total of 34 participants completed the questionnaire after both study phases. The mean age of the 
study cohort was 69 years (range: 50-86 years) and the average duration of PD was 10 years (range: 
2-26 years). Mean MMSE score was 28.6 (range: 26-30). All participants wore the sensors for the 
duration of phase one; 32 did so for the entirety of phase two. Two patients did not complete phase 
two: one withdrew after five days (unwell) and one after four days (discomfort wearing sensor); 
however both participants completed the phase two questionnaire.  
608 (99.3%) of a possible 612 responses to the questionnaire items from both phases were 
completed, with only four invalid responses (three blank, one dual-selection). The frequency of 
responses to items for each phase are presented in Table 1 below.  
Only one participant reported a preference for keeping a symptom diary as opposed to wearing the 
sensors; this was the participant who withdrew due to sensor discomfort. After completion of phase 
two, 32/34 (94.1%) participants agreed that they were willing to wear the sensors at home and 
29/34 (85.3%) participants agreed that they were willing to wear the sensors in public. 
Analysis of participants’ responses between study phases revealed a statistically significant (p<0.05) 
change (towards less agreement) in the responses to items one [the sensor looks like it is well 
made], two [the sensor is comfortable to wear] and five [I would be happy to wear the sensor 
around the house]. Table 2 displays the magnitude and frequency of change for these three items. 
On further examination it was evident that the majority of participants showed no change in their 
responses. For participants whose responses declined in agreement it is evident that the majority 
did so only by one category, with more pronounced swings in opinion (change ≥2 categories) being 
rare. A change in opinion of ≥2 categories was only expressed by 2/34 (5.9%) of participants to Item 
1, 3/34 (8.8%%) to Item 2 and 2/34 (5.9%) to Item 5). There was no significant difference between 
the study phases for the responses to the remaining five items considered for both phases of the 
study.  
For items 1, 2 and 5, further analysis was undertaken following contraction of the 5-point Likert scale 
into a 3-point scale: the responses strongly agree and agree were combined to ‘agreement’; strongly 
disagree and disagree to ‘disagreement’; neither agree nor disagree remained unchanged. Analysis 
using the 3-point scale found no statistically significant change in participants’ responses between 
study phases for items one and five (p=0.180 and 0.414 respectively). A statistically significant 
decrease (towards less agreement) in the responses to item two was evident (p=0.023)  
Questionnaire: Qualitative data 
13 participants (38.2%) provided free-text feedback in the post-CARU questionnaire; 18 (52.9%) did 
so in the questionnaire completed after the home monitoring period. In total, 25 different 
participants (73.5%) provided free-text feedback on at least one occasion during the study. 
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Content analysis, performed as described above, revealed three over-arching themes that are 
presented below: ‘Appearance (Table 3), ‘Useability’ (Table 4) and ‘Comfort’ (Table 5). ‘Appearance’ 
was sub-divided into ‘Physical properties’ and ‘Wearing in public’. Both ‘Useability’ and ‘Comfort’ 
were sub-divided according to sentiment (positive or negative).  
Accelerometer data 
The mean duration of ‘non-wear time’ (time during home monitoring waking hours where the 
sensors were not worn) was 228.2 minutes (SD = 385.3), equivalent to 32.6 minutes per day. The 
large standard deviation value is in part explained by one participant who represents a clear outlier. 
This participant discontinued home monitoring after 4 days citing sensor discomfort and wore the 
sensors for only 40.3% of home monitoring waking hours. When this outlier was excluded, the mean 
duration of “non-wear” time was 159.7 minutes (SD = 150.9); equivalent to 22.8 minutes per day 
(2.72% of waking hours). 
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4 Discussion   
This is the first study to our knowledge to carry out a thorough, detailed evaluation of the 
acceptability of body-worn sensors in PD. Our research suggests that long-term monitoring with 
body-worn sensors is acceptable to PD patients – a critical finding, since patient non-concordance 
with the wearing of a sensor renders even the most sensitive and accurate device virtually useless. 
Strengths of the work are the triangulation of data from multiple sources to reinforce the validity of 
our findings, and the consideration of acceptability after both a short and a prolonged period of 
wearing.  
After prolonged wearing participants were less likely to agree that the sensors were comfortable to 
wear. The mixed methods approach we adopted in this work enabled us to triangulate data and to 
obtain more detailed insight into participants’ experiences of wearing the sensors, since participants 
were provided with an opportunity to voice their agenda(19). Qualitative data revealed that the 
main source of sensor discomfort related to the strap. Furthermore, some participants reported 
problems with ill-fitting straps that resulted in relative motion between the sensor and the body – 
the resulting extraneous signal artefact may have adversely affected the quality of data 
captured(20). As a consequence of these findings the strap material, and the method for adjusting 
the sizing of it, were modified for the latest iteration of the sensor. 
Previous research in PD has invariably failed to consider the views of the wearer; Van Someren et 
al.(21), for example, suggested that wearing a wrist-worn sensor for several weeks would be “no 
more uncomfortable than wearing a wrist-watch”. This is a gross over-simplification and fails to 
appreciate the psychology associated with the wearing of a medical device.  
Despite a decline in patients’ views on sensor comfort and their willingness to wear them at home, 
this did not translate into patients not wearing the sensors, since concordance, as evidenced by the 
accelerometer-derived wear-time data, was high. On average (excluding an outlier) participants only 
removed the sensors for approximately 22 minutes per day - participants were invited to remove the 
sensors during washing/bathing and this period of non-wear time may represent such activities.  
Lehoux(22) suggested that user-acceptance may also depend on the context in which a sensor is 
worn, with patients often more self-conscious outside their ‘private sphere’. Social embarrassment 
and the feeling that wearing such a product marked a person as ‘old’, has been highlighted as a 
major factor affecting acceptability of body-worn sensors(23). Our findings suggest that long-term 
monitoring with body-worn sensors is acceptable to PD patients and that the vast majority of 
participants were willing to wear the sensor both at home and in public, a critical component of 
ensuring ecological validity of the recorded data.  
The only detailed previous work on sensor acceptability in PD(24) showed, in contrast to our 
findings, a large disparity between participants’ willingness to wear sensors at home and in public 
(Yes: 94% and 55% respectively). If the wearing of a sensor results in modification of the wearer’s 
behaviour, then the ecological validity of the data collected is limited. Critically, Giuffrida et al.(24) 
polled participants’ views in the presence of researchers, in a research facility, and did so after 
participants had only worn the sensors for a short period. It is possible that these factors may have 
introduced bias, resulting in false reassurance about the sensors’ acceptability. It is recognised that a 
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degree of obtrusiveness is inevitable with even the most well designed sensor and this may be 
magnified by more prolonged monitoring periods(25). In our study, polling views after the period of 
prolonged monitoring did not reveal marked deterioration in the wearability of the sensor, as might 
be expected if the sensor was not user-friendly(25). 
It is well recognised that patient concordance with home diaries, the current gold standard for home 
monitoring in PD, can be poor, and that entries are often not made contemporaneously(26). Our 
work revealed that participants overwhelmingly preferred wearing the sensor to completing a diary. 
Cognitive impairment is common in PD(27) and may impact on a person’s ability to accurately 
complete a home diary; consequently, such patients are frequently under-represented in clinical 
trials. Body-worn sensors may in future, enable remote monitoring of patients who are unable to 
maintain symptom diaries. It is however acknowledged that the acceptability of sensors in this group 
is not yet established, since cognitively impaired patients were not involved in this work. 
A potential limitation of our work is that the study population may not be truly reflective of the 
wider PD population. Those engaging with such a research project may be more willing to wear such 
a sensor. We believe that this effect is likely to be minimal since the study inclusion criteria were 
broad, thus reflecting a spectrum of disease, and the study protocol was not particularly arduous. 10 
patients did decline participation in the study; none cited unwillingness to wear the sensors as their 
reason for non-participation. Secondly, this research used only wrist-worn sensors and thus our 
conclusions may not be applicable to sensors worn elsewhere on the body; less conspicuous sensor 
placement may further improve acceptability. 
This research has highlighted the central importance of patient acceptability to home-monitoring 
systems. A recent United Kingdom Department of Health mandate(28) targeted increased 
availability of home-monitoring of chronic long-term health conditions by 2017. In this respect, 
prolonged monitoring requires a sensor to be as un-obtrusive and as wearable as possible to avoid 
declining patient concordance during the monitoring period(25). Our work has demonstrated the 
acceptability of the sensors employed and has highlighted the need to consider patients’ views when 
such systems are trialled. Further research might explore the acceptability of sensors worn in other 
body areas or modification of the wrist-worn sensor to include a functioning watch-face, which may 
improve acceptability further. 
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5 Conclusions 
• The wearer’s perspective must be considered when body-worn technology is being 
developed and evaluated. 
• Bilateral wrist worn sensors were acceptable to our population of patients with Parkinson’s 
disease, even after a period of prolonged wearing. 
• There was no evidence that participants were less likely to wear the sensors in public; a key 
finding to support the ecological validity of the data captured. 
• A mixed methods approach allowed triangulation of data relating to the patient experience 
and has directly informed further development of the sensor.  
 
Page 10 of 19
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Telemedicine and e-Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution11  
6 References 
1. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A Five-Year Study of the 
Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole 
or Levodopa. New England Journal of Medicine. 2000;342(20):1484-91. 
2. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement 
Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): 
Scale presentation and clinimetric testing results. Movement Disorders. 2008;23(15):2129-70. 
3. Post B, Merkus MP, de Bie RMA, de Haan RJ, Speelman JD. Unified Parkinson's Disease 
Rating Scale Motor Examination: Are Ratings of Nurses, Residents in Neurology , and Movement 
Disorders Specialists Interchangeable? Movement Disorders. 2005;20(12):1577-84. 
4. Vitale C, Pellecchia MT, Grossi D, Fragassi N, Cuomo T, Di Miao L, et al. Unawareness of 
dyskinesias in Parkinson's and Huntington's diseases. Neurological Sciences. 2001;22:105-6. 
5. Reimer J, Grabowski M, Lindvall O, Hagell P. Use and interpretation of on/off diaries in 
Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 2004;75:396-400. 
6. Hoff JI, Wagemans EA, van Hilten BJ. Ambulatory objective assessment of tremor in 
Parkinson's disease. Clinical Neuropharmacology. [Research Support, Non-U.S. Gov't]. 2001 Sep-
Oct;24(5):280-3. 
7. Cancela J, Pansera M, Arredondo MT, Estrada JJ, Pastorino M, Pastor-Sanz L, et al., editors. A 
comprehensive motor symptom monitoring and management system: The bradykinesia case. 
Engineering in Medicine and Biology Society (EMBC), 2010 Annual International Conference of the 
IEEE; 2010 Aug. 31 2010-Sept. 4 2010. 
8. Keijsers NLW, Horstink MWIM, Gielen SCAM. Automatic assessment of levodopa-induced 
dyskinesias in daily life by neural networks. Movement Disorders. [Comparative Study Research 
Support, Non-U.S. Gov't]. 2003 Jan;18(1):70-80. 
9. Griffiths RI, Kotschet K, Arfon S, Xu ZM, Johnson W, Drago J, et al. Automated Assessment of 
Bradykinesia and Dyskinesia in Parkinson's Disease. Journal of Parkinson's Disease. 2012;2(1):47-55. 
10. Deane KHO, Flaherty H, Daley DJ, Pascoe R, Penhale B, Clarke V, et al. Priority setting 
partnership to identify the top 10 research priorities for the management of Parkinson’s disease. 
BMJ Open. 2014;2014;4:e006434.doi:10.1136/bmjopen-2014-006434. 
11. Evans JR, Barker RA. Defining meaningful outcome measures in trials of disease-modifying 
therapies in Parkinson's disease. Expert Opin Pharmacother. 2011;12(8):1249-58. 
12. Davis MM, Freeman M, Kaye J, Vuckovic N, Buckley DI. A Systematic Review of Clinician and 
Staff Views on the Acceptability of Incorporating Remote Monitoring Technology into Primary Care. 
Telemedicine and e-Health. 2014;20(5):428-38. 
Page 11 of 19
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Telemedicine and e-Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution12  
13. Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for 
objective assessment of Parkinson's disease. Movement Disorders. 2013;28(12):1628-37. 
14. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic 
Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 1988;51(6):745-52. 
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 
1967;17(5):427-42. 
16. Folstein MF, Folstein SE. "Mini-Mental State". A Practical Method for Grading the Cognitive 
State of Patients for the Clinician. Journal of Psychiatric Research. 1975;12:189-98. 
17. Axivity AX3 3 Axis Logging Accelerometer: Data Sheet.  2013 [21st December 2013]; 
Available from: http://axivity.com/v2/products/AX3/AX3-1.7-Datasheet.pdf. 
18. Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging 
the dog? BMJ. [Journal Article]. 2001;322(7294):1115-7. 
19. O'Cathain A, Thomas K. "Any other comments?" Open questions on questionnaires - a bane 
or a bonus to research? BMC Medical Research Methodology. 2004;4(1):25. 
20. Yang C-C, Hsu Y-L. A Review of Accelerometry-Based Wearable Motion Detectors for Physical 
Activity Monitoring. Sensors. 2010;10(8):7772-88. 
21. van Someren EJW, van Gool WA, Vonk BFM, Mirmiran M, Speelman JD, Bosch DA, et al. 
Ambulatory monitoring of tremor and other movements before and after thalamotomy: A new 
quantitative technique. Journal of the Neurological Sciences. 1993;117(1–2):16-23. 
22. Lehoux P. Patients' perspectives on high-tech home care: a qualitative inquiry into the user-
friendliness of four technologies. BMC health services research. 2004;4(1):28. 
23. Peeters PHF. Design criteria for an automatic safety-alarm system for elderly. Technology 
and Health Care. 2000;8(2):81-91. 
24. Giuffrida JP, Riley DE, Maddux BN, Heldmann DA. Clinically deployable kinesia technology for 
automated tremor assessment: Movement Disorders. 2009;24(5):723-730 
25. Bonato P. Advances in wearable technology and its medical applications. Conference 
Proceedings:  Annual International Conference of the IEEE Engineering in Medicine & Biology 
Society. 2010;2021-4. 
26. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with 
paper diaries. British Medical Journal. 2002;324:1193-4. 
27. Weintraub D, Burn DJ. Parkinson's Disease: The Quintessential Neuropyschiatric Disorder. 
Movement Disorders. 2011;26(6):1022-31. 
28. The Mandate: A mandate from the Government to the NHS Commissioning Board: April 
2013 to March 2015. In: Health Do, editor. London: Williams Lea; 2012. 
Page 12 of 19
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Telemedicine and e-Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution13  
7  Acknowledgements 
We would like to acknowledge the help of all the participants in the trial.  
We would like to acknowledge the help of Kate Greenwell (KG) with the qualitative analysis in this 
work 
This study was funded by Northumbria Healthcare NHS Foundation Trust.   
 
L.Rochester is supported by the National Institute for Health Research (NIHR) Newcastle Biomedical 
Research Unit based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle 
University. The research was also supported by NIHR Newcastle CRF Infrastructure funding. The 
views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the 
Department of Health. 
 
No conflicts of interest exist for any of the contributing authors 
This study underwent full ethical review and was given a favourable ethical opinion by County 
Durham and Tees valley Research Ethics Committee. It was therefore performed in accordance with 
the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. 
Name and address of the individual to whom queries should be directed:  
Dr James Fisher. Northumbria Healthcare NHS Foundation Trust.  Department of Medicine. North 
Tyneside General Hospital. Rake Lane. North Shields. Tyne and Wear. United Kingdom.  
 
 
 
Page 13 of 19
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Telemedicine and e-Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution
  
 
 
Bilateral wrist-worn sensors  
85x64mm (150 x 150 DPI)  
 
 
Page 14 of 19
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Telemedicine and e-Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution
Table 1: Frequency of responses to questionnaire after CARU and Home phases 
  Frequency of response 
Item 
Strongly 
Agree 
Agree 
Neither 
Agree Nor 
Disagree 
Disagree 
Strongly 
Disagree 
1*) The sensor looks like it is well 
made 
CARU 13 21 0 0 0 
HOME 4 28 1 0 1 
2*) The sensor is comfortable to 
wear 
CARU 12 21 1 0 0 
HOME 3 25 3 3 0 
3) The sensor feels heavy on my 
arm 
CARU 0 0 3 19 12 
HOME 0 1 4 15 14 
4) Performing the assessments 
was made more difficult by 
wearing the sensor 
CARU 0 0 0 17 16 
HOME$           
5*) I would be happy to wear the 
sensor around the house 
CARU 15 18 1 0 0 
HOME 9 23 1 1 0 
6) I would rather keep a regular 
diary of my symptoms for a week 
than wear the sensor for a week 
CARU 0 0 5 18 11 
HOME 0 1 6 18 9 
7) If the sensor was incorporated 
into a working wrist-watch I would 
be more likely to wear it 
CARU 4 16 5 8 1 
HOME 5 13 7 6 2 
8) The sensor is easy to take on 
and off 
CARU 8 19 5 1 0 
HOME 5 24 2 2 0 
9) I would be happy to wear the 
sensor in public 
CARU 10 23 1 0 0 
HOME 7 22 3 2 0 
       
* statistically significant difference in responses CARU - home (p<0.05)  
$ 
question excluded as not relevance to home phase of study   
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Table 1: Scale and frequency of the change in response for items where a significant difference 
was detected 
 
Change in 
response 
Frequency 
 
The sensor 
looks like it is 
well made 
(Item 1) 
The sensor is 
comfortable to 
wear 
(Item 2) 
I would be 
happy to wear 
the sensor 
around the 
house 
(Item 5) 
M
o
re
  
  
 
p
o
si
ti
v
e
 -
>
 
+4 0 0 0 
+3 0 0 0 
+2 0 0 0 
+1 0 1 2 
No change 0 24 19 24 
<
- 
M
o
re
 
n
e
g
a
ti
v
e
 -1 8 11 6 
-2 1 2 2 
-3 1 1 0 
-4 0 0 0 
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Table 3: Content Analysis: Appearance 
APPEARANCE 
Patient 
ID 
Phase Comment   
GHRS Home 
"Would prefer it to be a little smaller and with watch face as keep thinking 
it was a watch I was wearing" 
Physical 
properties 
UVTR Home "The only problem was that I kept looking to find the time!" 
MZGE Home "Wore it for a week, did not cover it up" 
Wearing in 
public 
GHRS Home 
"I would not like to wear in warm summer months as more noticeable to 
people and questions" 
GHRS CARU 
"Happy to wear (in public) but would not like members of public 
questioning what it is for as illness is private" 
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Table 4: Content Analysis: Useability 
 
USEABILITY 
Patient 
ID 
Phase Comment 
  
MXRL Home "I had expected it to interfere with my everyday life but that did not happen" 
Positive 
WDSJ CARU "Someone will do [put on/off] for me" 
MUCL CARU "The sensor was very easy to have on" 
MUCL Home "The sensor I found easy to wear" 
ATYY Home "The sensor is easy to take on and off" 
PQEP Home 
"Because I have small wrists the sensors were swinging around and it was 
difficult to keep them in the upright position. After a couple of hours I used 
some surgical tape to stick it down where the strap fastens underneath - they 
are in the same position after one week including daily showers 
Negative 
GHRS Home "Found it restricts you wearing tight sleeves on clothes" 
MUCL Home "Felt a little nervous having a shower" 
WDSJ Home 
"The left, blue sensor did not always stay securely in position and so needed 
occasional readjustment" 
FRMQ Home "I removed them whilst having a bath/shower because they became soggy" 
FRMQ Home "For someone with a tremor they are a little awkward" 
BRCN Home "Maybe stronger pins in the sensor would help, one came out" 
NRWL Home "Sensor a little awkward to fasten the strap… when feeling off" 
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Table 5: Content Analysis: Comfort 
COMFORT 
Patient 
ID 
Phase Comment 
CGLT CARU "It feels no different to wearing a watch" 
Positive 
QXLL CARU "Feels comfortable, don't mind having it on" 
MXRL Home "Found the sensor quite comfortable to wear" 
QXZV Home "Very comfortable to wear - just like wearing a watch" 
MZGE Home "No problem. Forgot it was there" 
QXLL Home "No problems with sensor, almost forgot it was on" 
UGNK CARU "Strap would be more comfortable if leather" 
Negative 
LAPC Home "Velcro slightly uncomfortable" 
FRMQ Home "The sensor is slightly scratchy especially when wearing a watch as well" 
ATYY Home 
"It is always on your skin, also, when it gets wet it is very uncomfortable 
to wear generally and I don’t like it very much" 
GHRS Home 
"Comfortable to wear, however, after a week of constant wear feeling a 
little irritating" 
JKVJ Home "If strap were more comfortable would make wearing very easy" 
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